A detailed history of Bsw Wealth Partners transactions in Abb Vie Inc. stock. As of the latest transaction made, Bsw Wealth Partners holds 9,596 shares of ABBV stock, worth $1.61 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
9,596
Previous 9,010 6.5%
Holding current value
$1.61 Million
Previous $1.55 Million 22.65%
% of portfolio
0.29%
Previous 0.25%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$163.84 - $199.33 $96,010 - $116,807
586 Added 6.5%
9,596 $1.9 Million
Q2 2024

Jul 16, 2024

BUY
$154.79 - $180.76 $14,395 - $16,810
93 Added 1.04%
9,010 $1.55 Million
Q1 2024

Apr 23, 2024

SELL
$159.82 - $182.1 $51,142 - $58,272
-320 Reduced 3.46%
8,917 $1.62 Million
Q4 2023

Jan 25, 2024

SELL
$137.6 - $154.97 $16,787 - $18,906
-122 Reduced 1.3%
9,237 $1.43 Million
Q3 2023

Oct 27, 2023

BUY
$133.59 - $154.65 $16,030 - $18,558
120 Added 1.3%
9,359 $1.4 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $91,431 - $113,781
-690 Reduced 6.95%
9,239 $1.24 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $12,581 - $14,488
-87 Reduced 0.87%
9,929 $1.58 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $15,490 - $18,577
112 Added 1.13%
10,016 $1.62 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $6,576 - $7,542
49 Added 0.5%
9,904 $1.33 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $47,478 - $60,361
345 Added 3.63%
9,855 $1.51 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $108,883 - $135,093
825 Added 9.5%
9,510 $1.54 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $276,524 - $349,883
2,574 Added 42.12%
8,685 $1.18 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $59,690 - $67,757
-561 Reduced 8.41%
6,111 $659,000
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $48,607 - $54,151
-462 Reduced 6.48%
6,672 $751,000
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $156,621 - $172,421
-1,531 Reduced 17.67%
7,134 $772,000
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $65,035 - $87,805
808 Added 10.28%
8,665 $928,000
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $18,814 - $22,081
-219 Reduced 2.71%
7,857 $688,000
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $67,793 - $90,718
924 Added 12.92%
8,076 $793,000
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $88,042 - $133,483
1,365 Added 23.59%
7,152 $545,000
Q4 2019

Feb 18, 2020

BUY
$72.13 - $90.25 $15,291 - $19,133
212 Added 3.8%
5,787 $512,000
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $52,588 - $63,226
835 Added 17.62%
5,575 $422,000
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $58,407 - $74,658
889 Added 23.08%
4,740 $345,000
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $2,468 - $2,905
32 Added 0.84%
3,851 $310,000
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $18,917 - $23,330
243 Added 6.8%
3,819 $352,000
Q3 2018

Nov 09, 2018

BUY
$88.91 - $98.84 $44,988 - $50,013
506 Added 16.48%
3,576 $338,000
Q2 2018

Aug 07, 2018

BUY
$89.78 - $106.23 $448 - $531
5 Added 0.16%
3,070 $284,000
Q1 2018

May 10, 2018

BUY
$92.01 - $123.21 $18,309 - $24,518
199 Added 6.94%
3,065 $290,000
Q4 2017

Feb 08, 2018

BUY
$89.56 - $98.21 $1,432 - $1,571
16 Added 0.56%
2,866 $277,000
Q3 2017

Nov 03, 2017

BUY
$69.85 - $89.22 $199,072 - $254,277
2,850
2,850 $253,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bsw Wealth Partners Portfolio

Follow Bsw Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bsw Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Bsw Wealth Partners with notifications on news.